Cargando…
The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
Treatment of hyperkalemia with intravenous insulin-dextrose is associated with a risk of hypoglycemia. We aimed to determine the factors associated with hypoglycemia (glucose < 3.9 mmol/L, or < 70 mg/dL) and the critical time window with the highest incidence. In a retrospective cohort study i...
Autores principales: | Crnobrnja, Ljiljana, Metlapalli, Manogna, Jiang, Cathy, Govinna, Mauli, Lim, Andy K. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745028/ https://www.ncbi.nlm.nih.gov/pubmed/33328554 http://dx.doi.org/10.1038/s41598-020-79180-7 |
Ejemplares similares
-
The Effect of Patient Factors and Cotreatments on the Magnitude of Potassium Lowering with Insulin–Glucose Treatment in Patients with Hyperkalemia
por: Lim, Andy K. H., et al.
Publicado: (2021) -
Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosis
por: Lim, Andy K H, et al.
Publicado: (2021) -
Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease
por: Apel, Jill, et al.
Publicado: (2014) -
Oral Dextrose Gel Reduces the Need for Intravenous Dextrose Therapy in Neonatal Hypoglycemia
por: Rawat, Munmun, et al.
Publicado: (2016) -
Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and Results in Reduced Hypoglycemia
por: McNicholas, Bairbre A., et al.
Publicado: (2017)